Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2

被引：56
|
作者：
Chen, Sha [1 ]
Wang, Qian [1 ]
Christodoulou, Andriana [4 ]
Mylonas, Nikolaos [4 ]
Bakker, Diane [1 ]
Nederlof, Rianne [5 ,6 ]
Hollmann, Markus W. [1 ]
Weber, Nina C. [1 ]
Coronel, Ruben [2 ]
Wakker, Vincent [3 ]
Christoffels, Vincent M. [3 ]
Andreadou, Ioanna [4 ]
Zuurbier, Coert J. [1 ]
机构：
[1] Univ Amsterdam, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Amsterdam UMC,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Expt Cardiol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[4] Natl & Kapodistrian Univ Athens, Pharmacol Lab, Fac Pharm, Athens, Greece
[5] Heinrich Heine Univ Dusseldorf, Med Fak, Inst Herz & Kreislaufphysiol, Dusseldorf, Germany
[6] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Dusseldorf, Germany
来源：
CIRCULATION | 2023年 / 147卷 / 03期
关键词：
body weight; empagliflozin; glucose; infarct size; ischemia; reperfusion; ketones; sodium-glucose cotransporter 2 inhibitor;
D O I：
10.1161/CIRCULATIONAHA.122.061688
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：276 / 279
页数：4
相关论文
共 50 条
  • [1] Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor
    Koch, Richard A.
    Clark, Richard F.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (05) : E590 - E591
  • [2] Sodium-glucose cotransporter-2 inhibitor prescribing practices
    Alcorn, Chris
    Subarajan, Prathayini
    Kesari, Aditya
    Lockhart, Marie
    Cottrell, Daryl
    Jordan, Kim
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1136 - 1139
  • [3] Pros of Inpatient Sodium Glucose Cotransporter-2 Inhibitor Use
    Romo, Karina G.
    Gianchandani, Roma
    ENDOCRINE PRACTICE, 2024, 30 (04) : 398 - 401
  • [4] Lack of Interaction Between the Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin and Warfarin in Healthy Subjects
    Macha, Sreeraj
    Rose, Peter
    Mattheus, Michaela
    Pinnetti, Sabine
    Woerle, Hans J.
    DIABETES, 2012, 61 : A613 - A614
  • [5] Sodium-glucose cotransporter-2 inhibitor-associated thrombocytopenia
    Bando, Hironori
    Hirota, Yushi
    Ogawa, Wataru
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025, 24 (01): : 165 - 166
  • [6] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [7] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [8] The Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Empagliflozin, a Potent Sodium Glucose Cotransporter-2 Inhibitor
    Macha, Sreeraj
    Rose, Peter
    Mattheus, Michaela
    Cinca, Rodica M.
    Pinnetti, Sabine
    Broedl, Uli C.
    Woerle, Han J.
    DIABETES, 2012, 61 : A274 - A275
  • [9] Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor, Coadministered with Sitagliptin in Healthy Volunteers
    Brand, Tobias
    Macha, Sreeraj
    Mattheus, Michaela
    Pinnetti, Sabine
    Woerle, Hans J.
    ADVANCES IN THERAPY, 2012, 29 (10) : 889 - 899
  • [10] Empagliflozin: Primus Inter Pares Among Sodium-Glucose Cotransporter-2 Inhibitors?
    Biondi-Zoccai, Giuseppe
    Frati, Giacomo
    Peruzzi, Mariangela
    Booz, George W.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 84 (03) : 271 - 275
12345